Ubiquitin-mediated proteasomal degradation of Rho proteins by the CNF1 toxin

被引:34
作者
Doye, A [1 ]
Boyer, L [1 ]
Mettouchi, A [1 ]
Lemichez, E [1 ]
机构
[1] Kyushu Univ, Med Inst Bioregulat, Fukuoka 812, Japan
来源
METHODS IN ENZYMOLOGY, VOL 406, REGULATORS AND EFFECTORS OF SMALL GTPASES: RHO FAMILY | 2006年 / 406卷
关键词
D O I
10.1016/S0076-6879(06)06033-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The CNF1 toxin is produced by uropathogenic and meningitis-causing Escherichia coli. CNF1 catalyzes the constitutive activation of Rho proteins by deamidation. The threshold of activation of Rho proteins by CNF1 is, however, attenuated because of a concomitant decrease of their cellular levels. Depletion of activated-Rac1 is catalyzed by ubiquitin-mediated proteasomal degradation. Consequently, we show by effector-binding pull-down that co-treatment of intoxicated cells with the MG132 proteasome-inhibitor results in a higher level of activation of Rac, as well as RhoA and Cdc42. We show that CNF1 induces the transient recruitment of Rho proteins to cellular membranes. Interestingly, at the difference of Rac and Cdc42, the inhibition of the proteasome during CNF1 treatment does not result in a significant accumulation of RhoA to cellular membranes. Using an in vivo ubiquitylation assay, we evidence that mutation of the geranylgeranyl acceptor cysteine of Rac1 (Rac1(C189G)) abolished the sensitivity of permanently activated-Rac1 to ubiquitylation, whereas Rac1(C189G) remained able to bind to the effector-binding domain of p21-PAK. Collectively, these results indicate that association with the cellular membranes is a necessary step for activated-Rac1 ubiquitylation.
引用
收藏
页码:447 / 456
页数:10
相关论文
共 14 条
  • [1] CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion
    Doye, A
    Mettouchi, A
    Bossis, G
    Clément, R
    Buisson-Touati, C
    Flatau, G
    Gagnoux, L
    Piechaczyk, M
    Boquet, P
    Lemichez, E
    [J]. CELL, 2002, 111 (04) : 553 - 564
  • [2] ISOLATION AND NUCLEOTIDE-SEQUENCE OF THE GENE ENCODING CYTOTOXIC NECROTIZING FACTOR-I OF ESCHERICHIA-COLI
    FALBO, V
    PACE, T
    PICCI, L
    PIZZI, E
    CAPRIOLI, A
    [J]. INFECTION AND IMMUNITY, 1993, 61 (11) : 4909 - 4914
  • [3] Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine
    Flatau, G
    Lemichez, E
    Gauthier, M
    Chardin, P
    Paris, S
    Fiorentini, C
    Boquet, P
    [J]. NATURE, 1997, 387 (6634) : 729 - 733
  • [4] Foxman B, 2002, AM J MED, V113, p5S
  • [5] 67-kDa laminin receptor promotes internalization of cytotoxic necrotizing factor 1-expressing Escherichia coli K1 into human brain microvascular endothelial cells
    Kim, KJ
    Chung, JW
    Kim, KS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (02) : 1360 - 1368
  • [6] E-coli CNF1 toxin:: a two-in-one system for host-cell invasion
    Landraud, L
    Pulcini, C
    Gounon, P
    Flatau, G
    Boquet, P
    Lemichez, E
    [J]. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 293 (7-8) : 513 - 518
  • [7] Proteasomal degradation of cytotoxic necrotizing factor 1-activated Rac
    Lerm, M
    Pop, M
    Fritz, G
    Aktories, K
    Schmidt, G
    [J]. INFECTION AND IMMUNITY, 2002, 70 (08) : 4053 - 4058
  • [8] Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1:: Activation of cJun N-terminal kinase in HeLa cells
    Lerm, M
    Selzer, J
    Hoffmeyer, A
    Rapp, UR
    Aktories, K
    Schmidt, G
    [J]. INFECTION AND IMMUNITY, 1999, 67 (02) : 496 - 503
  • [9] PAK kinases are directly coupled to the PIX family of nucleotide exchange factors
    Manser, E
    Loo, TH
    Koh, CG
    Zhao, ZS
    Chen, XQ
    Tan, L
    Tan, I
    Leung, T
    Lim, L
    [J]. MOLECULAR CELL, 1998, 1 (02) : 183 - 192
  • [10] Activation and proteasomal degradation of rho GTPases by cytotoxic necrotizing factor-1 elicit a controlled inflammatory response
    Munro, P
    Flatau, G
    Doye, A
    Boyer, L
    Oregioni, O
    Mege, JL
    Landraud, L
    Lemichez, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (34) : 35849 - 35857